📣 VC round data is live. Check it out!
- Public Comps
- Apollo Hospitals
Apollo Hospitals Valuation Multiples
Discover revenue and EBITDA valuation multiples for Apollo Hospitals and similar public comparables like Aier EYE Hospital Group, DaVita, Encompass Health, Max Healthcare Institute and more.
Apollo Hospitals Overview
About Apollo Hospitals
Apollo Hospitals Enterprise Ltd operates a network of private hospitals in India through primary, secondary, and tertiary care facilities. The firm's tertiary care hospitals provide complex care in a variety of specialties that include cardiology, oncology, neuroscience, orthopedics, radiology, and gastroenterology. Apollo Hospitals also operates primary care and diagnostics clinics as well as telemedicine units and offers consulting, health insurance, education and training, and research services. Its reportable operating segments are; Healthcare Services (represents hospitals and hospitals services); Retail Health and Diagnostics (includes clinics and diagnostics); Digital Health and Pharmacy Distribution; and Others. Maximum revenue is generated from its Healthcare Services segment.
Founded
1979
HQ

Employees
18.6K
Website
Sectors
Financials (LTM)
EV
$13B
Valuation Multiples
Start free trialApollo Hospitals Financials
Apollo Hospitals reported last 12-month revenue of $3B and EBITDA of $402M.
In the same LTM period, Apollo Hospitals generated $1B in gross profit, $402M in EBITDA, and $211M in net income.
Revenue (LTM)
Apollo Hospitals P&L
In the most recent fiscal year, Apollo Hospitals reported revenue of $3B and EBITDA of $416M.
Apollo Hospitals is profitable as of last fiscal year, with gross margin of 48%, EBITDA margin of 16%, and net margin of 8%.
Financial data powered by Morningstar, Inc.
Apollo Hospitals Stock Performance
Apollo Hospitals has current market cap of $13B, and enterprise value of $13B.
Market Cap Evolution
Apollo Hospitals' stock price is $87.36.
Apollo Hospitals share price increased by 8.6% in the last 30 days, and by 17.3% in the last year.
Apollo Hospitals has an EPS (earnings per share) of $1.41.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $13B | $13B | 0.0% | 8.6% | 4.3% | 17.3% | $1.41 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialApollo Hospitals Valuation Multiples
Apollo Hospitals trades at 4.9x EV/Revenue multiple, and 32.8x EV/EBITDA.
EV / Revenue (LTM)
Apollo Hospitals Financial Valuation Multiples
As of May 25, 2026, Apollo Hospitals has market cap of $13B and EV of $13B.
Apollo Hospitals has a P/E ratio of 59.6x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Apollo Hospitals Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Apollo Hospitals Margins & Growth Rates
Apollo Hospitals grew revenue by 19% and EBITDA by 14% in the last fiscal year.
In the most recent fiscal year, Apollo Hospitals reported gross margin of 48%, EBITDA margin of 16%, and net margin of 8%.
Apollo Hospitals Margins
Apollo Hospitals Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Apollo Hospitals Operational KPIs
Apollo Hospitals' revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.1M for the same period.
Apollo Hospitals' Rule of 40 is 34% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Apollo Hospitals' Rule of X is 61% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Apollo Hospitals Competitors
Apollo Hospitals competitors include Aier EYE Hospital Group, DaVita, Encompass Health, Max Healthcare Institute, Rede D'Or São Luiz, Tenet Healthcare, Mayapada Hospital, Universal Health Services, Bangkok Dusit Medical Services and Fortis Healthcare.
Most Apollo Hospitals public comparables operate across Hospitals & Clinics.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 3.9x | 3.7x | 13.2x | 12.8x | |||
| 1.9x | 1.8x | 9.0x | 8.9x | |||
| 2.2x | 2.1x | 9.3x | 10.0x | |||
| 12.0x | 11.3x | 39.8x | 38.5x | |||
| 1.5x | 1.5x | 7.1x | 8.1x | |||
| 1.2x | 1.2x | 5.5x | 5.5x | |||
| 67.3x | — | 700.0x | — | |||
| 0.8x | 0.8x | 5.3x | 5.5x | |||
This data is available for Pro users. Sign up to see all Apollo Hospitals competitors and their valuation data. Start Free Trial | ||||||
Apollo Hospitals Funding History
Before going public, Apollo Hospitals raised $170M in total equity funding, across 1 round.
Apollo Hospitals Funding Rounds
Apollo Hospitals M&A Activity
Apollo Hospitals has acquired 3 companies to date.
Last acquisition by Apollo Hospitals was on October 5th 2022. Apollo Hospitals acquired AyurVAID for $3M (EV/Revenue multiple of ).
Latest Acquisitions by Apollo Hospitals
| Description | AyurVAID is India's largest chain of Ayurveda hospitals treating chronic conditions like diabetes and arthritis for low-income communities. | Assam Hospitals manages a network of multi-specialty facilities across Assam, India, providing comprehensive healthcare services including surgery, diagnostics, and emergency care. | Indore-based Raj Shree Hospital functions as a super specialty corporate facility delivering cardiology, neurology, orthopedics, gynecology, gastroenterology, and intensive care alongside emergency response, laboratory testing, radiology imaging, pharmacy services, ambulance transport, and blood bank operations. The hospital supports advanced procedures in joint replacement, spine surgery, laparoscopic operations, MRI diagnostics, CT scans, and rehabilitation programs plus preventive screenings for diabetes, obesity, and joint issues. |
| HQ Country | |||
| HQ City | Bangalore | Guwahati | Gorakhpur |
| Deal Date | 5 Oct 2022 | 2 Jun 2015 | 25 Jun 2014 |
| Valuation | $3M | $18M | $6M |
| EV/Revenue | |||
| EV/EBITDA | |||
This data is available for Pro users. Sign up to see all Apollo Hospitals acquisitions and their M&A valuation multiples. Start Free Trial | |||
Apollo Hospitals Investment Activity
Apollo Hospitals has invested in 4 companies to date.
Latest investment by Apollo Hospitals was on November 29th 2021. Apollo Hospitals invested in ZenOncoIO in their $1M Seed round (EV/Revenue multiple of ).
Latest Investments by Apollo Hospitals
| Description | ZenOncoIO is a Mumbai-based oncology network delivering integrated cancer care across 50 hospitals in India. Services encompass robotic surgery, precision chemotherapy, and proton therapy tailored by genomic profiling. The platform connects patients to specialists via telemedicine and AI-driven treatment planning. Launched in 2021, ZenOncoIO partners with Tata Memorial Hospital for rural outreach programs serving over 10,000 patients annually. | — | Impact Guru is a Mumbai-headquartered fintech platform enabling equity, reward, and donation-based crowdfunding for startups, nonprofits, and social enterprises across Asia. The company operates campaigns from offices in New Delhi, Singapore, Hong Kong, Jakarta, Kuala Lumpur, and San Francisco. Incubated at Harvard Innovation Lab in 2014, Impact Guru has raised $100 million for 5,000 projects including healthcare and disaster relief. | Medics International Lifesciences Ltd. is a superspecialty hospital in Kerala, India, delivering quaternary care through advanced infrastructure and equipment. Located in Perinthalmanna, it operates multiple facilities emphasizing ethical practices in cardiology, neurology, orthopedics, and oncology. The institution serves patients across northern Kerala with comprehensive diagnostic and surgical services. | |
| HQ Country | |||||
| HQ City | Bangalore | Bangalore | Mumbai | Lucknow | |
| Deal Date | 29 Nov 2021 | 25 Mar 2021 | 18 Dec 2018 | 5 Jul 2018 | |
| Round | Seed | Seed | Series A | Strategic investment | |
| Raised | $1M | $1M | $2M | $13M | |
| Investors | Apollo Hospitals; Arvind Kumar; Better Capital; Enzia Ventures; Titan Capital | 100Unicorns; Apollo Hospitals; Inflection Point Ventures; LVX Ventures; Venture Catalysts | Apollo Hospitals; Shorooq Partners; Venture Catalysts | Apollo Hospitals | |
| Valuation | undisclosed | undisclosed | undisclosed | $26M | |
| EV/Revenue | |||||
| EV/EBITDA | |||||
This data is available for Pro users. Sign up to see all Apollo Hospitals investments and their VC round multiples. Start Free Trial | |||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Apollo Hospitals
| When was Apollo Hospitals founded? | Apollo Hospitals was founded in 1979. |
| Where is Apollo Hospitals headquartered? | Apollo Hospitals is headquartered in India. |
| How many employees does Apollo Hospitals have? | As of today, Apollo Hospitals has over 18K employees. |
| Is Apollo Hospitals publicly listed? | Yes, Apollo Hospitals is a public company listed on National Stock Exchange of India. |
| What is the stock symbol of Apollo Hospitals? | Apollo Hospitals trades under APOLLOHOSP ticker. |
| When did Apollo Hospitals go public? | Apollo Hospitals went public in 1996. |
| Who are competitors of Apollo Hospitals? | Apollo Hospitals main competitors include Aier EYE Hospital Group, DaVita, Encompass Health, Max Healthcare Institute, Rede D'Or São Luiz, Tenet Healthcare, Mayapada Hospital, Universal Health Services, Bangkok Dusit Medical Services, Fortis Healthcare. |
| What is the current market cap of Apollo Hospitals? | Apollo Hospitals' current market cap is $13B. |
| What is the current revenue of Apollo Hospitals? | Apollo Hospitals' last 12 months revenue is $3B. |
| What is the current revenue growth of Apollo Hospitals? | Apollo Hospitals revenue growth (NTM/LTM) is 20%. |
| What is the current EV/Revenue multiple of Apollo Hospitals? | Current revenue multiple of Apollo Hospitals is 4.9x. |
| Is Apollo Hospitals profitable? | Yes, Apollo Hospitals is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Apollo Hospitals? | Apollo Hospitals' last 12 months EBITDA is $402M. |
| What is Apollo Hospitals' EBITDA margin? | Apollo Hospitals' last 12 months EBITDA margin is 15%. |
| What is the current EV/EBITDA multiple of Apollo Hospitals? | Current EBITDA multiple of Apollo Hospitals is 32.8x. |
| What is the current FCF of Apollo Hospitals? | Apollo Hospitals' last 12 months FCF is $71M. |
| What is Apollo Hospitals' FCF margin? | Apollo Hospitals' last 12 months FCF margin is 3%. |
| What is the current EV/FCF multiple of Apollo Hospitals? | Current FCF multiple of Apollo Hospitals is 185.7x. |
| How many companies Apollo Hospitals has acquired to date? | As of May 2026, Apollo Hospitals has acquired 3 companies. |
| What was the largest acquisition by Apollo Hospitals? | $18M acquisition of Assam Hospitals on 2nd June 2015 was the largest M&A Apollo Hospitals has done to date. |
| What companies Apollo Hospitals acquired? | Apollo Hospitals acquired Assam Hospitals, Raj Shree Hospital, and AyurVAID. |
| In how many companies Apollo Hospitals has invested to date? | As of May 2026, Apollo Hospitals has invested in 4 companies. |
| What was the last Apollo Hospitals investment? | On 29th November 2021 Apollo Hospitals invested in ZenOncoIO, participating in a $1M Seed round, alongside Arvind Kumar, Better Capital, Enzia Ventures, and Titan Capital. |
| In what companies Apollo Hospitals invested in? | Apollo Hospitals invested in Medics International Lifesciences Ltd., Impact Guru, ZenOncoIO, and Kindly His. |
See public comps similar to Apollo Hospitals
Lists including Apollo Hospitals
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.
